A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
There is no effective treatment modality available against different forms of leishmaniasis. Therefore, the aim of this study was to improve the penetration and efficacy of selenium and glucantime coupled with niosomes and compared them with their simple forms alone on in vitro susceptibility assays. In this study, the niosomal formulations of selenium and in combination with glucantime were prepared. The size and morphology of the niosomal formulations were charac- terized and the effectivity of the new formulation was also evaluated using in vitro MTT assay, intra-macrophage model, and gene expression profile. From the results obtained, no cytotoxicity effect was observed for niosomal and simple forms of drugs, as alone or in combination. Niosomal formulations of the drugs significantly showed more inhibitory ef- fects (P ≤ 0.001) than the simple drugs when the selectivity index was considered. The gene expression levels of Interleu- kin (IL-10) significantly decreased, while the level of IL-12 and metacaspase significantly increased (P ≤ 0.001). The results of the present study showed that selenium plus glucantime niosome possess a potent anti-leishmanial effect and en- hanced their lethal activity as evidenced by the in vitro experiments.
Abstract
There is no effective treatment modality available against different forms of leishmaniasis. Therefore, the aim of this study was to improve the penetration and efficacy of selenium and glucantime coupled with niosomes and compared them with their simple forms alone on in vitro susceptibility assays. In this study, the niosomal formulations of selenium and in combination with glucantime were prepared. The size and morphology of the niosomal formulations were charac- terized and the effectivity of the new formulation was also evaluated using in vitro MTT assay, intra-macrophage model, and gene expression profile. From the results obtained, no cytotoxicity effect was observed for niosomal and simple forms of drugs, as alone or in combination. Niosomal formulations of the drugs significantly showed more inhibitory ef- fects (P ≤ 0.001) than the simple drugs when the selectivity index was considered. The gene expression levels of Interleu- kin (IL-10) significantly decreased, while the level of IL-12 and metacaspase significantly increased (P ≤ 0.001). The results of the present study showed that selenium plus glucantime niosome possess a potent anti-leishmanial effect and en- hanced their lethal activity as evidenced by the in vitro experiments.
참고문헌 (42)
- Alvar J, "Leishmaniasis worldwide and global estimates of its incidence", PLoS One, 7, pp.e35671~ (2012)
- Alvar J, "Leishmaniasis and poverty", Trends Parasitol, 22, pp.552~557 (2006)
- Karimi A, "Spatial and temporal distributions of phlebotomine sand flies(Diptera : Psychodidae), vectors of leishmaniasis, in Iran", Acta Trop, 132, pp.131~139 (2014)
- Aflatoonian MR, "A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran", PLoS One, 9, pp.e89043~ (2014)
- Sharifi I, "A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern irannarrative review article", Iran J Public Health, 44, pp.299~307 (2015)
- Saghafipour A, "Outbreak of zoonotic cutaneous leishmaniasis : a report", Arch Hyg Sci, 2, pp.48~54 (2013)
- Torrado JJ, "Amphotericin B formulations and drug targeting", J Pharm Sci, 97, pp.2405~2425 (2008)
- Eddaikra N, "Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria", PLoS Negl Trop Dis, 12, pp.e0006310~ (2018)
- Mishra J, "Chemotherapy of leishmaniasis : past, present and future", Curr Med Chem, 14, pp.1153~1169 (2007)
- Rayman MP, "Selenium and human health", Lancet, 379, pp.1256~1268 (2012)
- Tapiero H, "The antioxidant role of selenium and seleno-compounds", Biomed Pharmacother, 57, pp.134~144 (2003)
- Mahmoudvand H, "In vitro study of leishmanicidal activity of biogenic selenium nanoparticles against Iranian isolate of sensitive and glucantime-resistant Leishmania tropica", Iran J Parasitol, 9, pp.452~460 (2014)
- Beheshti N, "Efficacy of biogenic selenium nanoparticles against Leishmania major : In vitro and in vivo studies", J Trace Elem Med Biol, 27, pp.203~207 (2013)
- Soflaei S, "Anti-leishmanial activities of selenium nanoparticles and selenium dioxide on Leishmania infantum", Comp Clin Path, 23, pp.15~20 (2014)
- Debnath A, "Structural and Functional significance of Niosome and Proniosome in Drug Delivery System", Int J Pharm and Eng, 3, pp.621~637 (2015)
- Mahale NB, "Niosomes : novel sustained release nonionic stable vesicular systems — an overview", Adv Colloid Interface Sci, 183, pp.46~54 (2012)
- Riabi TR, "Evaluation of a possible synergistic effect of meglumine antimoniate with paromomycin, miltefosine or allopurinol on in vitro susceptibility of Leishmania tropica resistant isolate", Iran J Parasitol, 8, pp.396~401 (2013)
- Uchegbu IF, "Non-ionic surfactant vesicles(niosomes) : physical and pharmaceutical chemistry", Adv Colloid Interface Sci, 58, pp.1~55 (1995)
- Koutsoni O, "Leishmania eukaryotic initiation factor(LeIF)inhibits parasite growth in murine macrophages", PLoS One, 9, pp.e97319~ (2014)
- Chandra D, "Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage", monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism, 2008, pp.154, 224~234
- Zhong M, "Selection of reference genes for quantitative gene expression studies in the house fly (Musca domestica L.) using reverse transcription quantitative real-time PCR", Acta Biochim Biophys Sin (Shanghai), 45, pp.1069~1073 (2013)
- S SK, "Comparative in-silico genome analysis of Leishmania(Leishmania)donovani : a step towards its species specificity", Meta gene, 2, pp.782~798 (2014)
- Kalat SA, "Use of topical liposomes containing meglumine antimoniate (Glucantime)for the treatment of L. major lesion in BALB", c mice, 2014, pp.143, 5~10
- Ag Seleci D, "Niosomes as nanoparticular drug carriers : fundamentals and recent applications", J Nanomater, 2016, pp.1~13 (2016)
- Lobanov A V, "Selenium metabolism in Trypanosoma : characterization of selenoproteomes and identification of a Kinetoplastida-specific selenoprotein", Nucleic Acids Res, 34, pp.4012~4024 (2006)
- Wlodkowic D, "Apoptosis and beyond : cytometry in studies of programmed cell death", Methods Cell Biol, 103, pp.55~98 (2011)
- Zhang J, "Comparison of short-term toxicity between Nano-Se and selenite in mice", Life Sci, 76, pp.1099~1109 (2005)
- Wang H, "Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes : Comparison with selenomethionine in mice", Free Radic Biol Med, 42, pp.1524~1533 (2007)
- de Souza CES, "Anti-Trypanosoma, anti-Leishmania and cytotoxic activities of natural products from Psidium brownianum Mart. ex DC. and Psidium guajava var. Pomifera analysed by LC-MS", Acta Trop, 176, pp.380~384 (2017)
- Martín-Montes Á, "Library of selenocompounds as novel agents against Leishmania species", Antimicrob Agents Chemother, 61, pp.1~13 (2017)
- Olliaro PL, "Drug combinations for visceral leishmaniasis", Curr Opin Infect Dis, 23, pp.595~602 (2010)
- Firooz A, "Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis : a randomized assessor-blind controlled trial", Arch Dermatol, 142, pp.1575~1579 (2006)
- Shamsi Meymandi S, "Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy", Arch Iran Med, 14, pp.238~243 (2011)
- Farajzadeh S, "Comparison between combination therapy of oral terbinafine and cryotherapy versus systemic meglumine antimoniate and cryotherapy in cutaneous leishmaniasis : a randomized clinical trial", Iran J Parasitol, 10, pp.1~8 (2015)
- Gannavaram S, "Modulation of innate immune mechanisms to enhance leishmania vaccine-induced immunity : role of coinhibitory molecules", Front Immunol, 7, pp.187~ (2016)
- Prajapati VK, "Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes", J Antimicrob Chemother, 66, pp.874~879 (2011)
- Bogdan BC, "Macrophage deactivation by interleukln 10", J Exp Med, 174, pp.1549~1555 (1991)
- Ambit A, "An essential role for the Leishmania major metacaspase in cell cycle progression", Cell Death Differ, 15, pp.113~122 (2008)
- Raina P, "Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani", Mol Cell Biochem, 359, pp.135~149 (2012)
- Lee N, "Programmed cell death in the unicellular protozoan parasite Leishmania", Cell Death Differ, 9, pp.53~64 (2002)
- Zalila H, "Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major", Mol Microbiol, 79, pp.222~239 (2011)
- Debrabant A, "Programmed cell death in trypanosomatids and other unicellular organisms", Int J Parasitol, 33, pp.257~267 (2003)